Roche's Actemra I just received an email for my
Post# of 148074
I just received an email for my corporate entity of dramatic increases in utilization at roughly $4000 per dose despite no EUA and to require usage criteria..
Desperate times indeed, wow how can we solve this?
I'm in the camp of submitting to FDA, demand a no instead of the slow roll,
what are we worried about SP decreasing on an actual letter?